HHealth Read More Study reveals how a promising bacterial therapy reduces recurrent bacterial vaginosisMarch 28, 2026 A new study from the Kwon Lab at the Ragon Institute, published in Cell Host & Microbe, provides the most detailed…
HHealth Read More Oral semaglutide fails to slow early Alzheimer’s decline in two phase 3 trialsMarch 23, 2026 Despite hopes raised by earlier observational studies and biomarker shifts, The Lancet trials found that oral semaglutide did…
HHealth Read More Romiplostim prevents chemotherapy-induced thrombocytopenia in phase 3 trialMarch 13, 2026 Results from a global phase 3 clinical trial led by investigators at Mass General Brigham show that the…
HHealth Read More Low‑dose oral lithium may help slow the decline of verbal memory, trial suggestsMarch 2, 2026 Lithium-a decades-old treatment for bipolar disorder-may hold potential neuroprotective benefits beyond mood stabilization. An exploratory clinical trial from…
TTechnology Read More Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesityFebruary 25, 2026 Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial of dapiglutide, researchers…
HHealth Read More Psychedelic effects of ketamine do not predict sobrietyFebruary 17, 2026 The psychedelic effects recreational users often seek from taking ketamine do not predict the therapeutic benefits for people…
HHealth Read More Magnesium lower fasting blood sugar in older adultsFebruary 13, 2026 A carefully controlled trial finds that magnesium can lower fasting glucose in older adults with magnesium deficiency, but…
HHealth Read More Tirzepatide shows dual benefits in sleep apnea trial improving metabolism and reducing inflammationFebruary 10, 2026 New clinical trial evidence suggests targeting both obesity and sleep-disordered breathing together may reshape cardiometabolic risk management in…
HHealth Read More Novel neuroprotective drug improves recovery after acute ischemic strokeFebruary 8, 2026 Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48…
TTechnology Read More Red light therapy may protect athletes’ brains from repetitive impactsJanuary 22, 2026 Punch-drunk syndrome, boxer’s madness, chronic traumatic encephalopathy (CTE). The name has changed over the years, but the cause…
HHealth Read More Early treatment delays rheumatoid arthritis onset in high-risk individualsJanuary 21, 2026 Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease…
SScience Read More Ashwagandha aids recovery without blunting training stress in athletesJanuary 18, 2026 A controlled trial in team-sport athletes suggests Ashwagandha may help maintain hormonal balance and support recovery and power…